# Preliminary Evidence of Blood DNA Methylation Changes in Pregnant Women Adhering to a Mediterranean Diet

**Authors:** Grace Tavelli, Nikki Schultz, Joanna Brisbane, Nina Kresoje, Samantha Lodge, Jeremy K. Nicholson, Nicola J. Armstrong, Desiree Silva, Nina D’Vaz, David Martino

PMC · DOI: 10.3390/epigenomes10010012 · Epigenomes · 2026-02-13

## TL;DR

This study found some small changes in blood DNA methylation in pregnant women who followed a Mediterranean diet, linked to genes involved in metabolism and inflammation.

## Contribution

The study provides preliminary evidence of methylation changes in specific genes associated with Mediterranean diet adherence during pregnancy.

## Key findings

- 2210 differentially methylated regions were identified, enriched in metabolic, inflammatory, and neuronal pathways.
- Nine novel DMR associations were replicated using publicly available data.
- Small methylation changes in LPIN1, COL18A1, and PPARGC1B were linked to inflammatory markers and diet adherence.

## Abstract

Background/Objectives: Consumption of a Mediterranean diet (MD) has been associated with reduced incidence of non-communicable diseases and reduced overall mortality, with epigenomic effects representing plausible mediators. The aim of this pilot study was to explore potential epigenetic associations between DNA methylation markers in blood and adherence to an MD in pregnancy. Methods: Fifty-two pregnant women with high or low adherence to an MD throughout pregnancy, who participated in the BioMood ORIGINS study, were selected using an extremes-of-exposure design. DNA methylation (DNAm) profiles from whole blood were generated using the TWIST human methylome panel. We conducted both genome-wide and candidate gene-based differential methylation analyses to identify epigenetic variations between the study groups. Furthermore, we explored potential associations between blood methylation patterns and circulating inflammatory markers (GlycA, GlycB and SPC) previously observed to exhibit differential abundance in the same cohort of women. Results: There were no genome-wide significant differences in methylated dinucleotides between MD groups (p-value < 5 × 10−8); however, a region-based analysis identified 2210 differentially methylated regions (DMRs) (FDR < 0.05, absolute maximum logFC > 1) annotated to 1537 genes, significantly enriched in metabolic, inflammatory and neuronal signaling pathways. Leveraging publicly available data, we replicated nine novel DMR associations. Changes in circulating phospholipid inflammatory markers were significantly associated with a small methylation difference in Lipin-1 (LPIN1), albeit with a small effect size (p-value < 5 × 10−8). A look-up analysis of previously reported MD-associated genes in this cohort detected small but statistically significantly different methylation of CpGs located within collagen type XVIII alpha 1 (COL18A1) and peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PPARGC1B) gene regions. Conclusions: We provide preliminary evidence for modest methylation changes in specific genes associated with adherence to an MD.

## Linked entities

- **Genes:** Lpin1 (lipin 1) [NCBI Gene 14245], COL18A1 (collagen type XVIII alpha 1 chain) [NCBI Gene 80781], PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522]

## Full-text entities

- **Genes:** TBP (TATA-box binding protein) [NCBI Gene 6908] {aka GTF2D, GTF2D1, HDL4, SCA17, TBP1, TFIID}, LIPE (lipase E, hormone sensitive type) [NCBI Gene 3991] {aka AOMS4, FPLD6, HSL, LHS, REH}, PPARGC1B (PPARG coactivator 1 beta) [NCBI Gene 133522] {aka ERRL1, PERC, PGC-1(beta), PGC1B}, PCSK2 (proprotein convertase subtilisin/kexin type 2) [NCBI Gene 5126] {aka NEC 2, NEC-2, NEC2, PC2, SPC2}, RENBP (renin binding protein) [NCBI Gene 5973] {aka RBP, RNBP}, PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}, RNF223 (ring finger protein 223) [NCBI Gene 401934], TMEM184A (transmembrane protein 184A) [NCBI Gene 202915] {aka SDMG1, SLC51C1}, IL4I1 (interleukin 4 induced 1) [NCBI Gene 259307] {aka FIG1, LAAO, LAO, hIL4I1}, LPIN1 (lipin 1) [NCBI Gene 23175] {aka PAP1}, PILRB (paired immunoglobin like type 2 receptor beta) [NCBI Gene 29990] {aka FDFACT1, FDFACT2}, RUNX3 (RUNX family transcription factor 3) [NCBI Gene 864] {aka AML2, CBFA3, PEBP2aC}, IFRD1 (interferon related developmental regulator 1) [NCBI Gene 3475] {aka PC4, TIS7}, EEF2 (eukaryotic translation elongation factor 2) [NCBI Gene 1938] {aka EEF-2, EF-2, EF2, SCA26}, MOK (MOK protein kinase) [NCBI Gene 5891] {aka RAGE, RAGE-1, RAGE1, STK30}, PRKG1 (protein kinase cGMP-dependent 1) [NCBI Gene 5592] {aka AAT8, PKG, PKG1, PRKG1B, PRKGR1B, cGK}, TWIST1 (twist family bHLH transcription factor 1) [NCBI Gene 7291] {aka ACS3, BPES2, BPES3, CRS, CRS1, CSO}, APCDD1 (APC down-regulated 1) [NCBI Gene 147495] {aka B7323, DRAPC1, FP7019, HHS, HTS, HYPT1}, PDE9A (phosphodiesterase 9A) [NCBI Gene 5152] {aka HSPDE9A2}, AKT3 (AKT serine/threonine kinase 3) [NCBI Gene 10000] {aka MPPH, MPPH2, PKB-GAMMA, PKBG, PRKBG, RAC-PK-gamma}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, LEPR (leptin receptor) [NCBI Gene 3953] {aka CD295, LEP-R, LEPRD, OB-R, OBR, huB219}, PDE1C (phosphodiesterase 1C) [NCBI Gene 5137] {aka DFNA74, Hcam3, cam-PDE 1C, hCam-3}, SPCS1 (signal peptidase complex subunit 1) [NCBI Gene 28972] {aka HSPC033, SPC1, SPC12, YJR010C-A}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PLAGL1 (PLAG1 like zinc finger 1) [NCBI Gene 5325] {aka LOT1, ZAC, ZAC1}, IFI30 (IFI30 lysosomal thiol reductase) [NCBI Gene 10437] {aka GILT, IFI-30, IP-30, IP30}, SFTPC (surfactant protein C) [NCBI Gene 6440] {aka BRICD6, PSP-C, SFTP2, SMDP2, SP-C}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, COL18A1 (collagen type XVIII alpha 1 chain) [NCBI Gene 80781] {aka GLCC, KNO, KNO1, KS}, KCNN2 (potassium calcium-activated channel subfamily N member 2) [NCBI Gene 3781] {aka DYT34, KCa2.2, NEDMAB, SK2, SKCA2, SKCa 2}, TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1) [NCBI Gene 10454] {aka 3'-Tab1, MAP3K7IP1}
- **Diseases:** allergies (MESH:D004342), systemic (MESH:D015619), inflammatory bowel diseases (MESH:D015212), type 2 diabetes (MESH:D003924), phospholipid (MESH:D016736), cardiovascular disease (MESH:D002318), MD (MESH:D007161), NCDs (MESH:D000073296), anxiety (MESH:D001007), asthma (MESH:D001249), cancers (MESH:D009369), Inflammation (MESH:D007249), neurodegenerative diseases (MESH:D019636), injury to (MESH:D014947)
- **Chemicals:** calcium (MESH:D002118), folate (MESH:D005492), glucose (MESH:D005947), lipid (MESH:D008055), amino acids (MESH:D000596), Lignans (MESH:D017705), olive oil (MESH:D000069463), GlycB (-), iron (MESH:D007501), phospholipid (MESH:D010743), Flavonols (MESH:D044948), triacylglycerol (MESH:D014280), Sulforaphane (MESH:C016766), MDA (MESH:D015104), glycosphingolipid (MESH:D006028), vitamin D. (MESH:D014807), cGMP (MESH:D006152)
- **Species:** gut metagenome (species) [taxon 749906], Allium cepa (onion, species) [taxon 4679], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921938/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921938/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921938/full.md

---
Source: https://tomesphere.com/paper/PMC12921938